🇺🇸 Epoetin alpha in United States

37 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 6 reports (16.22%)
  2. Platelet Count Decreased — 5 reports (13.51%)
  3. Diarrhoea — 4 reports (10.81%)
  4. Renal Failure Acute — 4 reports (10.81%)
  5. Abdominal Pain — 3 reports (8.11%)
  6. Anaemia — 3 reports (8.11%)
  7. Confusional State — 3 reports (8.11%)
  8. Drug Ineffective — 3 reports (8.11%)
  9. Fall — 3 reports (8.11%)
  10. Haemoglobin Decreased — 3 reports (8.11%)

Source database →

Epoetin alpha in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Epoetin alpha approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Epoetin alpha in United States?

University Medical Center Groningen is the originator. The local marketing authorisation holder may differ — check the official source linked above.